A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy

Neurology

Volumn 60, Issue 2, 2003, Pages 196-202

  Gilliam, F G ^e,f   Veloso, F ^a   Bomhof, M A M ^b   Gazda, S K ^g   Biton, V ^g   Ter Bruggen, J P ^c   Neto, W ^d   Bailey, C ^d   Pledger, G ^d   Wu, S C ^d   Alving, J ^g   Arroyo, S ^g   Arts, R ^g   Ayala, R ^g   Barbano, R ^g   Ben Menachem, E ^g   Blume, W ^g   Brodtkorb, E ^g   Browne, T R ^g   Chadwick, D ^g   Couch, C ^g   Crumrine, P K ^g   Dam, M ^g   De Deyn, P P ^g   Dellaportas, C ^g   Desai, H ^g   Edwards, K R ^g   Engelsen, B ^g   Farran, R D ^g   Frank, L M ^g   French, J ^g   Friedman, A J ^g   Gelbum, J ^g   Harden, C L ^g   Hart, C ^g   Henriksen, O ^g   Hoffstetter, M D ^g   Holt, P J ^g   Hulihan, J F ^g   Hull, R P ^g   Husainy, T ^g   Kang, H ^g   Kern, R ^g   Kirzinger, S S ^g   Lee, M A ^g   Leroy, R F ^g   Licht, J ^g   Mai, J ^g   Michelucci, R ^g   Morris, G L ^g   Mutani, R ^g   Narus, M ^g   Nieto Barrera, M ^g   Nisman Safirstein, M ^g   Ogunyemi, A ^g   Pak, J ^g   Pennell, P B ^g   Phillips, S G ^g   Pillay, N ^g   Ramsay, R E ^g   Ritter, F J ^g   Rogers Neame, N T ^g   Rosenfeld, W E ^g   Schneiderman, J ^g   Singer, R ^g   So, N K ^g   Soederfeldt, B ^g   Soryall, I N ^g   Sperling, M ^g   Starreveld, E ^g   Steinhoff, B J ^g   Stodiek, S R G ^g   Tans, J T J ^g   Todorov, A B ^g   Van Orman, C B ^g   Veilleux, M ^g   Waltimo, O ^g   Wannamaker, B B ^g   Weaver, D ^g   Zagnoni, P ^g   more..

^a Saskatchewan Health Authority   (Canada)

^b Ignatius Hospital   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

^d JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^e WASHINGTON UNIVERSITY   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; TOPIRAMATE;

ADOLESCENT; ADULT; AGED; ANOREXIA; ARTICLE; CHILD; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EARLY DIAGNOSIS; FATIGUE; FEMALE; FOCAL EPILEPSY; HEADACHE; HUMAN; HYPESTHESIA; INSOMNIA; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; NEPHROLITHIASIS; NERVOUSNESS; PARESTHESIA; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; STATISTICAL ANALYSIS; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VERTIGO; WEIGHT REDUCTION;

EID: 0037469199     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000048200.12663.BC     Document Type: Article

References (25)

1. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 1997;28:167-179.
2. Koh S, Jensen FE. Topiramate blocks perinatal hypoxia-induced seizures in rat pups. Ann Neurol 2001;50:366-372.
3. Faught E, Wilder BJ, Ramsay RE, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology 1996;46:1684-1690.
4. Privitera M, Fincham R, Penry J, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1000-mg daily dosages. Neurology 1996;46:1678-1683.
5. Sharief M, Viteri C, Ben-Menachem E, et al. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 1996;25:217-224.
6. Tassinari CA, Michelucci R, Chauvel P, et al. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996;37:763-768.
7. Ben-Menachem E, Henriksen O, Dam M, Mikkelsen M, et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996;37:539-543.
8. Elterman RD, Glauser TA, Wyllie E, et al. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 1999;52:1338-1344.
9. Sachdeo RC, Glauser TA, Ritter F, et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999;52:1882-1887.
10. Biton V, Montouris GD, Ritter F, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology 1999;52:1330-1337.
11. Temple RT, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part I: Ethical and scientific issues. Ann Intern Med 2000;133:455-463.
12. Ellenberg SS, Temple RT. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: Practical issues and specific cases. Ann Intern Med 2000;133:464-470.
13. Pledger GW, Kramer LD. Clinical trials of investigational antiepileptic drugs: monotherapy designs. Epilepsia 1991;32:716-721.
14. Sachdeo RC, Reife RA, Lim P, et al. Topiramate monotherapy for partial onset seizures. Epilepsia 1997;38:294-300.
15. Guberman A, Neto W, Gassman-Mayer C. Topiramate 200 mg/day as the target dose for add-on therapy in adults. Neurology 2001;56(suppl 3):A332. [Abstract].
16. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.
17. Lachin JM, Foulkes MA. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics 1986;42:507-515.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
19. Cox DR. Regression models and life tables. J R Stat Soc Ser B 1972;34:187-220.
20. Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989;84:1065-1073.
21. Kwan PK, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-319.
22. Mattson RH, Cramer JA, Collins JF, and the Dept. of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. A comparison of valproate with carbamazepine for the treatment of partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 1992;327:765-771.
23. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic clonic seizures. N Engl J Med 1985;313:145-151.
24. Brodie MA, Richens A, Yuen AWC, et al. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-479.
25. Steiner TJ, Dellaportas CI, Findley LJ, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 1999;40:601-607.